-
The Growth of Vaccines Beyond Infectious Disease
Suzanne Elvidge
April 19, 2024
Vaccination for infectious diseases saves two to three million lives a year worldwide, according to the World Health Organization (WHO).
-
Understanding how COVID-19 affects children vital to slowing pandemic
worldpharmanews
March 20, 2020
Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately.
-
Individual response to COVID-19 'as important' as government action
worldpharmanews
March 09, 2020
How individuals respond to government advice on preventing the spread of COVID-19 will be at least as important, if not more important, than government action ...
-
Finland’s Mobidiag forms JV with Autobio to bring its infectious disease assays to China
fiercebiotech
December 18, 2018
Mobidiag has paired up with China’s Autobio Diagnostics to help launch its infectious disease assays in the country through a new joint venture.
-
Global coalition backs Imperial College London’s RNA vaccine platform to fight ‘Disease X’
fiercepharma
December 11, 2018
One of the first missions that the Coalition for Epidemic Preparedness Innovations (CEPI) set when it came into being in 2017 was to facilitate development of vaccine platforms that can be quickly adopted
-
Brexit Health Alliance calls for co-operation on infectious diseases
pharmatimes
July 10, 2018
The Brexit Health Alliance is warning that efforts to prevent the spread of infectious diseases in the UK could be under threat if the country pulls out of the EU’s early warning system without having a suitable replacement.
-
Atlas awarded £2m grant for infectious disease test
pharmatimes
August 16, 2017
Atlas Genetics has been awarded a £2 million grant by Innovate UK for a project that aims to support the adoption of its io rapid diagnostic platform into UK sexual health clinics.
-
Karius reels in $50M to ramp up infectious disease liquid biopsy
fiercebiotech
August 08, 2017
Karius plans to launch its blood-based test that detects more than 1,250 pathogens nationwide this year
-
Chikungunya vaccines: Themis, Bharat Biotech kick off new testing
fiercepharma
June 07, 2017
As the hunt to develop the world's first Chikungyuna vaccine persists, two biotechs kicked off tests for their respective programs on Monday.
-
VivaGel BV granted QIDP and Fast Track designation by FDA
cphi-online
January 16, 2017
Product receives designations for both the BV treatment and prevention indications.